Clinical trial NCT00808067: RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
Official title: RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Atrial Fibrillation
Lead sponsor: Boehringer Ingelheim
Sponsor class: INDUSTRY
First posted: 2008-12-15
Enrollment: 5897
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purposes of this study are:

1. To evaluate the long-term safety of dabigatran etexilate
2. To assess the effect of a knowledge translation intervention on patient outcomes


Eligibility criteria: Inclusion criteria:

Participation in RE-LY, requires long term anticoagulation, provides written informed consent

Exclusion criteria:

Permanent discontinuation of dabigatran during RE-LY

Primary outcomes:
measure: Major Bleeding, Annualized Rate of Subjects With Major Bleeds
timeFrame: up to 43 months
Secondary outcomes:
measure: Stroke, Annualized Rate of Subjects With Stroke
timeFrame: up to 43 months
measure: Non CNS Systemic Embolism (SEE), Annualized Rate of Subjects With Non-CNS SEE
timeFrame: up to 43 months
measure: Pulmonary Embolism (PE), Annualized Rate of Subjects With PE
timeFrame: up to 43 months
measure: Acute Myocardial Infarction (MI), Annualized Rate of Subjects With MI
timeFrame: up to 43 months
measure: Deep Vein Thrombosis, Annualized Rate of Subjects With DVT
timeFrame: up to 43 months
measure: Death, Annualized Rate of Subject Death
timeFrame: up to 43 months
measure: Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE)
timeFrame: up to 43 months
measure: Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE) and All Cause Death
timeFrame: up to 43 months
measure: Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction, Vascular Death
timeFrame: up to 43 months
measure: Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction (MI), All Cause Death and Major Bleed
timeFrame: up to 43 months
measure: Annualized Rate of Subjects With Minor Bleeds
timeFrame: up to 43 months
measure: Annualized Rate of Subjects With Any Bleeds (Major Plus Minor)
timeFrame: up to 43 months
measure: Annualized Rate of Subjects With Intra-Cranial Hemorrhage (ICH)
timeFrame: up to 43 months
Other outcomes:
Locations:
city: Birmingham
country: United States
facility: 1160.71.0046 Boehringer Ingelheim Investigational Site
state: Alabama
city: Birmingham
country: United States
facility: 1160.71.0057 Boehringer Ingelheim Investigational Site
state: Alabama
city: Birmingham
country: United States
facility: 1160.71.0211 Boehringer Ingelheim Investigational Site
state: Alabama
city: Mobile
country: United States
facility: 1160.71.0115 Boehringer Ingelheim Investigational Site
state: Alabama
city: Lake Havasu City
country: United States
facility: 1160.71.0104 Boehringer Ingelheim Investigational Site
state: Arizona
city: Tucson
country: United States
facility: 1160.71.0185 Boehringer Ingelheim Investigational Site
state: Arizona
city: Hot Springs
country: United States
facility: 1160.71.0038 Boehringer Ingelheim Investigational Site
state: Arkansas
city: Jonesboro
country: United States
facility: 1160.71.0302 Boehringer Ingelheim Investigational Site
state: Arkansas
city: Little Rock
country: United States
facility: 1160.71.0191 Boehringer Ingelheim Investigational Site
state: Arkansas
city: Little Rock
country: United States
facility: 1160.71.0213 Boehringer Ingelheim Investigational Site
state: Arkansas
city: Carmichael
country: United States
facility: 1160.71.0441 Boehringer Ingelheim Investigational Site
state: California
city: Fullerton
country: United States
facility: 1160.71.0333 Boehringer Ingelheim Investigational Site
state: California
city: La Jolla
country: United States
facility: 1160.71.0384 Boehringer Ingelheim Investigational Site
state: California
city: Lancaster
country: United States
facility: 1160.71.0246 Boehringer Ingelheim Investigational Site
state: California
city: Merced
country: United States
facility: 1160.71.0070 Boehringer Ingelheim Investigational Site
state: California
city: Oakland
country: United States
facility: 1160.71.0349 Boehringer Ingelheim Investigational Site
state: California
city: Oceanside
country: United States
facility: 1160.71.0016 Boehringer Ingelheim Investigational Site
state: California
city: Pasadena
country: United States
facility: 1160.71.0459 Boehringer Ingelheim Investigational Site
state: California
city: Poway
country: United States
facility: 1160.71.0270 Boehringer Ingelheim Investigational Site
state: California
city: Riverside
country: United States
facility: 1160.71.0135 Boehringer Ingelheim Investigational Site
state: California
city: Sacramento
country: United States
facility: 1160.71.0300 Boehringer Ingelheim Investigational Site
state: California
city: San Diego
country: United States
facility: 1160.71.0284 Boehringer Ingelheim Investigational Site
state: California
city: Walnut Creek
country: United States
facility: 1160.71.0379 Boehringer Ingelheim Investigational Site
state: California
city: Colorado Springs
country: United States
facility: 1160.71.0321 Boehringer Ingelheim Investigational Site
state: Colorado
city: Colorado Springs
country: United States
facility: 1160.71.0449 Boehringer Ingelheim Investigational Site
state: Colorado
city: Denver
country: United States
facility: 1160.71.0360 Boehringer Ingelheim Investigational Site
state: Colorado
city: Denver
country: United States
facility: 1160.71.0413 Boehringer Ingelheim Investigational Site
state: Colorado
city: Fort Collins
country: United States
facility: 1160.71.0362 Boehringer Ingelheim Investigational Site
state: Colorado
city: Bridgeport
country: United States
facility: 1160.71.0278 Boehringer Ingelheim Investigational Site
state: Connecticut
city: Guilford
country: United States
facility: 1160.71.0482 Boehringer Ingelheim Investigational Site
state: Connecticut
city: Boynton Beach
country: United States
facility: 1160.71.0382 Boehringer Ingelheim Investigational Site
state: Florida
city: Brandon
country: United States
facility: 1160.71.0056 Boehringer Ingelheim Investigational Site
state: Florida
city: Clearwater
country: United States
facility: 1160.71.0296 Boehringer Ingelheim Investigational Site
state: Florida
city: Coral Springs
country: United States
facility: 1160.71.0327 Boehringer Ingelheim Investigational Site
state: Florida
city: Daytona Beach
country: United States
facility: 1160.71.0376 Boehringer Ingelheim Investigational Site
state: Florida
city: Fort Myers
country: United States
facility: 1160.71.0074 Boehringer Ingelheim Investigational Site
state: Florida
city: Jacksonville
country: United States
facility: 1160.71.0089 Boehringer Ingelheim Investigational Site
state: Florida
city: Jacksonville
country: United States
facility: 1160.71.0232 Boehringer Ingelheim Investigational Site
state: Florida
city: Jacksonville
country: United States
facility: 1160.71.0427 Boehringer Ingelheim Investigational Site
state: Florida
city: Lakeland
country: United States
facility: 1160.71.0012 Boehringer Ingelheim Investigational Site
state: Florida
city: Miami
country: United States
facility: 1160.71.0034 Boehringer Ingelheim Investigational Site
state: Florida
city: Orlando
country: United States
facility: 1160.71.0227 Boehringer Ingelheim Investigational Site
state: Florida
city: Ormond Beach
country: United States
facility: 1160.71.0095 Boehringer Ingelheim Investigational Site
state: Florida
city: Pensacola
country: United States
facility: 1160.71.0037 Boehringer Ingelheim Investigational Site
state: Florida
city: Port Charlotte
country: United States
facility: 1160.71.0137 Boehringer Ingelheim Investigational Site
state: Florida
city: Port Charlotte
country: United States
facility: 1160.71.0417 Boehringer Ingelheim Investigational Site
state: Florida
city: Rockledge
country: United States
facility: 1160.71.0332 Boehringer Ingelheim Investigational Site
state: Florida
city: Sarasota
country: United States
facility: 1160.71.0385 Boehringer Ingelheim Investigational Site
state: Florida
city: St. Petersburg
country: United States
facility: 1160.71.0015 Boehringer Ingelheim Investigational Site
state: Florida
city: St. Petersburg
country: United States
facility: 1160.71.0339 Boehringer Ingelheim Investigational Site
state: Florida
city: Vero Beach
country: United States
facility: 1160.71.0019 Boehringer Ingelheim Investigational Site
state: Florida
city: Atlanta
country: United States
facility: 1160.71.0159 Boehringer Ingelheim Investigational Site
state: Georgia
city: Augusta
country: United States
facility: 1160.71.0021 Boehringer Ingelheim Investigational Site
state: Georgia
city: Conyers
country: United States
facility: 1160.71.0161 Boehringer Ingelheim Investigational Site
state: Georgia
city: Cicero
country: United States
facility: 1160.71.0218 Boehringer Ingelheim Investigational Site
state: Illinois
city: Maywood
country: United States
facility: 1160.71.0438 Boehringer Ingelheim Investigational Site
state: Illinois
city: Melrose Park
country: United States
facility: 1160.71.0331 Boehringer Ingelheim Investigational Site
state: Illinois
city: Normal
country: United States
facility: 1160.71.0364 Boehringer Ingelheim Investigational Site
state: Illinois
city: North Chicago
country: United States
facility: 1160.71.0109 Boehringer Ingelheim Investigational Site
state: Illinois
city: Oak Lawn
country: United States
facility: 1160.71.0152 Boehringer Ingelheim Investigational Site
state: Illinois
city: Rockford
country: United States
facility: 1160.71.0198 Boehringer Ingelheim Investigational Site
state: Illinois
city: Winfield
country: United States
facility: 1160.71.0433 Boehringer Ingelheim Investigational Site
state: Illinois
city: Fort Wayne
country: United States
facility: 1160.71.0377 Boehringer Ingelheim Investigational Site
state: Indiana
city: Indianapolis
country: United States
facility: 1160.71.0288 Boehringer Ingelheim Investigational Site
state: Indiana
city: Indianapolis
country: United States
facility: 1160.71.0352 Boehringer Ingelheim Investigational Site
state: Indiana
city: Indianapolis
country: United States
facility: 1160.71.0436 Boehringer Ingelheim Investigational Site
state: Indiana
city: South Bend
country: United States
facility: 1160.71.0235 Boehringer Ingelheim Investigational Site
state: Indiana
city: Dubuque
country: United States
facility: 1160.71.0268 Boehringer Ingelheim Investigational Site
state: Iowa
city: West Des Moines
country: United States
facility: 1160.71.0001 Boehringer Ingelheim Investigational Site
state: Iowa
city: West Des Moines
country: United States
facility: 1160.71.0357 Boehringer Ingelheim Investigational Site
state: Iowa
city: Lexington
country: United States
facility: 1160.71.0422 Boehringer Ingelheim Investigational Site
state: Kentucky
city: Louisville
country: United States
facility: 1160.71.0178 Boehringer Ingelheim Investigational Site
state: Kentucky
city: Louisville
country: United States
facility: 1160.71.0397 Boehringer Ingelheim Investigational Site
state: Kentucky
city: Owensboro
country: United States
facility: 1160.71.0310 Boehringer Ingelheim Investigational Site
state: Kentucky
city: Baton Rouge
country: United States
facility: 1160.71.0144 Boehringer Ingelheim Investigational Site
state: Louisiana
city: Lafayette
country: United States
facility: 1160.71.0018 Boehringer Ingelheim Investigational Site
state: Louisiana
city: New Iberia
country: United States
facility: 1160.71.0132 Boehringer Ingelheim Investigational Site
state: Louisiana
city: Auburn
country: United States
facility: 1160.71.0096 Boehringer Ingelheim Investigational Site
state: Maine
city: Annapolis
country: United States
facility: 1160.71.0114 Boehringer Ingelheim Investigational Site
state: Maryland
city: Baltimore
country: United States
facility: 1160.71.0023 Boehringer Ingelheim Investigational Site
state: Maryland
city: Baltimore
country: United States
facility: 1160.71.0047 Boehringer Ingelheim Investigational Site
state: Maryland
city: Baltimore
country: United States
facility: 1160.71.0079 Boehringer Ingelheim Investigational Site
state: Maryland
city: Baltimore
country: United States
facility: 1160.71.0186 Boehringer Ingelheim Investigational Site
state: Maryland
city: Baltimore
country: United States
facility: 1160.71.0194 Boehringer Ingelheim Investigational Site
state: Maryland
city: Bel Air
country: United States
facility: 1160.71.0255 Boehringer Ingelheim Investigational Site
state: Maryland
city: Columbia
country: United States
facility: 1160.71.0398 Boehringer Ingelheim Investigational Site
state: Maryland
city: Rockville
country: United States
facility: 1160.71.0177 Boehringer Ingelheim Investigational Site
state: Maryland
city: Salisbury
country: United States
facility: 1160.71.0073 Boehringer Ingelheim Investigational Site
state: Maryland
city: Salisbury
country: United States
facility: 1160.71.0207 Boehringer Ingelheim Investigational Site
state: Maryland
city: Takoma Park
country: United States
facility: 1160.71.0196 Boehringer Ingelheim Investigational Site
state: Maryland
city: Towson
country: United States
facility: 1160.71.0187 Boehringer Ingelheim Investigational Site
state: Maryland
city: Westminster
country: United States
facility: 1160.71.0052 Boehringer Ingelheim Investigational Site
state: Maryland
city: Haverhill
country: United States
facility: 1160.71.0443 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: Haverhill
country: United States
facility: 1160.71.0452 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: Natick
country: United States
facility: 1160.71.0029 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: North Dartmouth
country: United States
facility: 1160.71.0003 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: Worcester
country: United States
facility: 1160.71.0308 Boehringer Ingelheim Investigational Site
state: Massachusetts
city: Grand Blanc
country: United States
facility: 1160.71.0154 Boehringer Ingelheim Investigational Site
state: Michigan
city: Lapeer
country: United States
facility: 1160.71.0205 Boehringer Ingelheim Investigational Site
state: Michigan
city: Muskegon
country: United States
facility: 1160.71.0279 Boehringer Ingelheim Investigational Site
state: Michigan
city: Petoskey
country: United States
facility: 1160.71.0445 Boehringer Ingelheim Investigational Site
state: Michigan
city: Rochester Hills
country: United States
facility: 1160.71.0274 Boehringer Ingelheim Investigational Site
state: Michigan
city: Saginaw
country: United States
facility: 1160.71.0165 Boehringer Ingelheim Investigational Site
state: Michigan
city: Troy
country: United States
facility: 1160.71.0020 Boehringer Ingelheim Investigational Site
state: Michigan
city: Ypsilanti
country: United States
facility: 1160.71.0188 Boehringer Ingelheim Investigational Site
state: Michigan
city: Minneapolis
country: United States
facility: 1160.71.0202 Boehringer Ingelheim Investigational Site
state: Minnesota
city: St. Paul
country: United States
facility: 1160.71.0101 Boehringer Ingelheim Investigational Site
state: Minnesota
city: Gulfport
country: United States
facility: 1160.71.0086 Boehringer Ingelheim Investigational Site
state: Mississippi
city: Tupelo
country: United States
facility: 1160.71.0119 Boehringer Ingelheim Investigational Site
state: Mississippi
city: Columbia
country: United States
facility: 1160.71.0055 Boehringer Ingelheim Investigational Site
state: Missouri
city: Kansas City
country: United States
facility: 1160.71.0257 Boehringer Ingelheim Investigational Site
state: Missouri
city: St. Charles
country: United States
facility: 1160.71.0336 Boehringer Ingelheim Investigational Site
state: Missouri
city: St. Louis
country: United States
facility: 1160.71.0249 Boehringer Ingelheim Investigational Site
state: Missouri
city: Kalispell
country: United States
facility: 1160.71.0027 Boehringer Ingelheim Investigational Site
state: Montana
city: Omaha
country: United States
facility: 1160.71.0110 Boehringer Ingelheim Investigational Site
state: Nebraska
city: Henderson
country: United States
facility: 1160.71.0346 Boehringer Ingelheim Investigational Site
state: Nevada
city: Las Vegas
country: United States
facility: 1160.71.0430 Boehringer Ingelheim Investigational Site
state: Nevada
city: Browns Mills
country: United States
facility: 1160.71.0142 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Cherry Hill
country: United States
facility: 1160.71.0221 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Flemington
country: United States
facility: 1160.71.0248 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Oakland
country: United States
facility: 1160.71.0478 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Ocean
country: United States
facility: 1160.71.0392 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Westwood
country: United States
facility: 1160.71.0254 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Woodland Park
country: United States
facility: 1160.71.0472 Boehringer Ingelheim Investigational Site
state: New Jersey
city: Albany
country: United States
facility: 1160.71.0476 Boehringer Ingelheim Investigational Site
state: New York
city: Bronx
country: United States
facility: 1160.71.0113 Boehringer Ingelheim Investigational Site
state: New York
city: Bronx
country: United States
facility: 1160.71.0281 Boehringer Ingelheim Investigational Site
state: New York
city: Cortlandt Manor
country: United States
facility: 1160.71.0044 Boehringer Ingelheim Investigational Site
state: New York
city: Mineola
country: United States
facility: 1160.71.0229 Boehringer Ingelheim Investigational Site
state: New York
city: Mineola
country: United States
facility: 1160.71.0451 Boehringer Ingelheim Investigational Site
state: New York
city: New Rochelle
country: United States
facility: 1160.71.0183 Boehringer Ingelheim Investigational Site
state: New York
city: Northport
country: United States
facility: 1160.71.0210 Boehringer Ingelheim Investigational Site
state: New York
city: Poughkeepsie
country: United States
facility: 1160.71.0075 Boehringer Ingelheim Investigational Site
state: New York
city: Troy
country: United States
facility: 1160.71.0414 Boehringer Ingelheim Investigational Site
state: New York
city: Watertown
country: United States
facility: 1160.71.0356 Boehringer Ingelheim Investigational Site
state: New York
city: Yonkers
country: United States
facility: 1160.71.0064 Boehringer Ingelheim Investigational Site
state: New York
city: Asheville
country: United States
facility: 1160.71.0353 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Charlotte
country: United States
facility: 1160.71.0080 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Gastonia
country: United States
facility: 1160.71.0350 Boehringer Ingelheim Investigational Site
state: North Carolina
city: High Point
country: United States
facility: 1160.71.0173 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Pinehurst
country: United States
facility: 1160.71.0006 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Statesville
country: United States
facility: 1160.71.0002 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Statesville
country: United States
facility: 1160.71.0069 Boehringer Ingelheim Investigational Site
state: North Carolina
city: Grand Forks
country: United States
facility: 1160.71.0102 Boehringer Ingelheim Investigational Site
state: North Dakota
city: Jamestown
country: United States
facility: 1160.71.0222 Boehringer Ingelheim Investigational Site
state: North Dakota
city: Akron
country: United States
facility: 1160.71.0203 Boehringer Ingelheim Investigational Site
state: Ohio
city: Canal Fulton
country: United States
facility: 1160.71.0434 Boehringer Ingelheim Investigational Site
state: Ohio
city: Cincinnati
country: United States
facility: 1160.71.0402 Boehringer Ingelheim Investigational Site
state: Ohio
city: Cincinnati
country: United States
facility: 1160.71.0426 Boehringer Ingelheim Investigational Site
state: Ohio
city: Cincinnati
country: United States
facility: 1160.71.0479 Boehringer Ingelheim Investigational Site
state: Ohio
city: Cleveland
country: United States
facility: 1160.71.0263 Boehringer Ingelheim Investigational Site
state: Ohio
city: Cleveland
country: United States
facility: 1160.71.0480 Boehringer Ingelheim Investigational Site
state: Ohio
city: Columbus
country: United States
facility: 1160.71.0267 Boehringer Ingelheim Investigational Site
state: Ohio
city: Dayton
country: United States
facility: 1160.71.0035 Boehringer Ingelheim Investigational Site
state: Ohio
city: Fairview Park
country: United States
facility: 1160.71.0150 Boehringer Ingelheim Investigational Site
state: Ohio
city: Kettering
country: United States
facility: 1160.71.0201 Boehringer Ingelheim Investigational Site
state: Ohio
city: Lorain
country: United States
facility: 1160.71.0223 Boehringer Ingelheim Investigational Site
state: Ohio
city: Lyndhurst
country: United States
facility: 1160.71.0214 Boehringer Ingelheim Investigational Site
state: Ohio
city: Sandusky
country: United States
facility: 1160.71.0275 Boehringer Ingelheim Investigational Site
state: Ohio
city: Westlake
country: United States
facility: 1160.71.0103 Boehringer Ingelheim Investigational Site
state: Ohio
city: Tulsa
country: United States
facility: 1160.71.0435 Boehringer Ingelheim Investigational Site
state: Oklahoma
city: Corvallis
country: United States
facility: 1160.71.0139 Boehringer Ingelheim Investigational Site
state: Oregon
city: Eugene
country: United States
facility: 1160.71.0325 Boehringer Ingelheim Investigational Site
state: Oregon
city: Springfield
country: United States
facility: 1160.71.0133 Boehringer Ingelheim Investigational Site
state: Oregon
city: Allentown
country: United States
facility: 1160.71.0301 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Camp Hill
country: United States
facility: 1160.71.0295 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Hershey
country: United States
facility: 1160.71.0294 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Jenkintown
country: United States
facility: 1160.71.0369 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Lancaster
country: United States
facility: 1160.71.0431 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Langhorne
country: United States
facility: 1160.71.0168 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Meadowbrook
country: United States
facility: 1160.71.0293 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Norristown
country: United States
facility: 1160.71.0394 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Pittsburgh
country: United States
facility: 1160.71.0466 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Sellersville
country: United States
facility: 1160.71.0208 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Uniontown
country: United States
facility: 1160.71.0465 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Wynnewood
country: United States
facility: 1160.71.0032 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Wyomissing
country: United States
facility: 1160.71.0067 Boehringer Ingelheim Investigational Site
state: Pennsylvania
city: Beaufort
country: United States
facility: 1160.71.0007 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Charleston
country: United States
facility: 1160.71.0383 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Greenville
country: United States
facility: 1160.71.0313 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Spartanburg
country: United States
facility: 1160.71.0166 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Summerville
country: United States
facility: 1160.71.0008 Boehringer Ingelheim Investigational Site
state: South Carolina
city: Chattanooga
country: United States
facility: 1160.71.0084 Boehringer Ingelheim Investigational Site
state: Tennessee
city: Clinton
country: United States
facility: 1160.71.0474 Boehringer Ingelheim Investigational Site
state: Tennessee
city: Germantown
country: United States
facility: 1160.71.0062 Boehringer Ingelheim Investigational Site
state: Tennessee
city: Johnson City
country: United States
facility: 1160.71.0370 Boehringer Ingelheim Investigational Site
state: Tennessee
city: Nashville
country: United States
facility: 1160.71.0395 Boehringer Ingelheim Investigational Site
state: Tennessee
city: Austin
country: United States
facility: 1160.71.0129 Boehringer Ingelheim Investigational Site
state: Texas
city: Austin
country: United States
facility: 1160.71.0410 Boehringer Ingelheim Investigational Site
state: Texas
city: Dallas
country: United States
facility: 1160.71.0156 Boehringer Ingelheim Investigational Site
state: Texas
city: Fort Worth
country: United States
facility: 1160.71.0315 Boehringer Ingelheim Investigational Site
state: Texas
city: Houston
country: United States
facility: 1160.71.0447 Boehringer Ingelheim Investigational Site
state: Texas
city: Killeen
country: United States
facility: 1160.71.0483 Boehringer Ingelheim Investigational Site
state: Texas
city: Lubbock
country: United States
facility: 1160.71.0335 Boehringer Ingelheim Investigational Site
state: Texas
city: San Antonio
country: United States
facility: 1160.71.0269 Boehringer Ingelheim Investigational Site
state: Texas
city: San Antonio
country: United States
facility: 1160.71.0307 Boehringer Ingelheim Investigational Site
state: Texas
city: San Marcos
country: United States
facility: 1160.71.0285 Boehringer Ingelheim Investigational Site
state: Texas
city: Tyler
country: United States
facility: 1160.71.0367 Boehringer Ingelheim Investigational Site
state: Texas
city: Charlottesville
country: United States
facility: 1160.71.0453 Boehringer Ingelheim Investigational Site
state: Virginia
city: Chesapeake
country: United States
facility: 1160.71.0053 Boehringer Ingelheim Investigational Site
state: Virginia
city: Fredericksburg
country: United States
facility: 1160.71.0428 Boehringer Ingelheim Investigational Site
state: Virginia
city: Harrisonburg
country: United States
facility: 1160.71.0311 Boehringer Ingelheim Investigational Site
state: Virginia
city: Newport News
country: United States
facility: 1160.71.0292 Boehringer Ingelheim Investigational Site
state: Virginia
city: Salem
country: United States
facility: 1160.71.0220 Boehringer Ingelheim Investigational Site
state: Virginia
city: Suffolk
country: United States
facility: 1160.71.0224 Boehringer Ingelheim Investigational Site
state: Virginia
city: Winchester
country: United States
facility: 1160.71.0317 Boehringer Ingelheim Investigational Site
state: Virginia
city: Bellingham
country: United States
facility: 1160.71.0050 Boehringer Ingelheim Investigational Site
state: Washington
city: Burien
country: United States
facility: 1160.71.0040 Boehringer Ingelheim Investigational Site
state: Washington
city: Spokane
country: United States
facility: 1160.71.0250 Boehringer Ingelheim Investigational Site
state: Washington
city: Tacoma
country: United States
facility: 1160.71.0256 Boehringer Ingelheim Investigational Site
state: Washington
city: Wenatchee
country: United States
facility: 1160.71.0024 Boehringer Ingelheim Investigational Site
state: Washington
city: Clarksburg
country: United States
facility: 1160.71.0169 Boehringer Ingelheim Investigational Site
state: West Virginia
city: Huntington
country: United States
facility: 1160.71.0365 Boehringer Ingelheim Investigational Site
state: West Virginia
city: Madison
country: United States
facility: 1160.71.0099 Boehringer Ingelheim Investigational Site
state: Wisconsin
city: Milwaukee
country: United States
facility: 1160.71.0072 Boehringer Ingelheim Investigational Site
state: Wisconsin
city: Milwaukee
country: United States
facility: 1160.71.0461 Boehringer Ingelheim Investigational Site
state: Wisconsin
city: Coffs Harbour
country: Australia
facility: 1160.71.0508 Boehringer Ingelheim Investigational Site
state: New South Wales
city: Gosford
country: Australia
facility: 1160.71.0510 Boehringer Ingelheim Investigational Site
state: New South Wales
city: Milton
country: Australia
facility: 1160.71.0506 Boehringer Ingelheim Investigational Site
state: Queensland
city: Ashford
country: Australia
facility: 1160.71.0509 Boehringer Ingelheim Investigational Site
state: South Australia
city: Launceston
country: Australia
facility: 1160.71.0507 Boehringer Ingelheim Investigational Site
state: Tasmania
city: Box Hill
country: Australia
facility: 1160.71.0504 Boehringer Ingelheim Investigational Site
state: Victoria
city: Geelong
country: Australia
facility: 1160.71.0501 Boehringer Ingelheim Investigational Site
state: Victoria
city: Graz
country: Austria
facility: 1160.71.0543 Boehringer Ingelheim Investigational Site
city: Linz
country: Austria
facility: 1160.71.0549 Boehringer Ingelheim Investigational Site
city: Wien
country: Austria
facility: 1160.71.0541 Boehringer Ingelheim Investigational Site
city: Wien
country: Austria
facility: 1160.71.0542 Boehringer Ingelheim Investigational Site
city: Wien
country: Austria
facility: 1160.71.0545 Boehringer Ingelheim Investigational Site
city: Wien
country: Austria
facility: 1160.71.0547 Boehringer Ingelheim Investigational Site
city: Wien
country: Austria
facility: 1160.71.0548 Boehringer Ingelheim Investigational Site
city: Wr. Neustadt
country: Austria
facility: 1160.71.0550 Boehringer Ingelheim Investigational Site
city: Aalst
country: Belgium
facility: 1160.71.0564 Boehringer Ingelheim Investigational Site
city: Brasschaat
country: Belgium
facility: 1160.71.0572 Boehringer Ingelheim Investigational Site
city: Brussel
country: Belgium
facility: 1160.71.0571 Boehringer Ingelheim Investigational Site
city: Bruxelles
country: Belgium
facility: 1160.71.0581 Boehringer Ingelheim Investigational Site
city: Bruxelles
country: Belgium
facility: 1160.71.0585 Boehringer Ingelheim Investigational Site
city: Edegem
country: Belgium
facility: 1160.71.0563 Boehringer Ingelheim Investigational Site
city: Genk
country: Belgium
facility: 1160.71.0578 Boehringer Ingelheim Investigational Site
city: Genk
country: Belgium
facility: 1160.71.0587 Boehringer Ingelheim Investigational Site
city: Gent
country: Belgium
facility: 1160.71.0574 Boehringer Ingelheim Investigational Site
city: Gilly
country: Belgium
facility: 1160.71.0588 Boehringer Ingelheim Investigational Site
city: Hasselt
country: Belgium
facility: 1160.71.0568 Boehringer Ingelheim Investigational Site
city: Leuven
country: Belgium
facility: 1160.71.0561 Boehringer Ingelheim Investigational Site
city: Liège
country: Belgium
facility: 1160.71.0579 Boehringer Ingelheim Investigational Site
city: Oostende
country: Belgium
facility: 1160.71.0567 Boehringer Ingelheim Investigational Site
city: Roeselare
country: Belgium
facility: 1160.71.0570 Boehringer Ingelheim Investigational Site
city: Tienen
country: Belgium
facility: 1160.71.0566 Boehringer Ingelheim Investigational Site
city: Turnhout
country: Belgium
facility: 1160.71.0562 Boehringer Ingelheim Investigational Site
city: Campinas
country: Brazil
facility: 1160.71.0644 Boehringer Ingelheim Investigational Site
city: Curitiba
country: Brazil
facility: 1160.71.0650 Boehringer Ingelheim Investigational Site
city: Curitiba
country: Brazil
facility: 1160.71.0651 Boehringer Ingelheim Investigational Site
city: Goiania
country: Brazil
facility: 1160.71.0652 Boehringer Ingelheim Investigational Site
city: Sao Jose do Riio Preto
country: Brazil
facility: 1160.71.0646 Boehringer Ingelheim Investigational Site
city: São José do Rio Preto
country: Brazil
facility: 1160.71.0647 Boehringer Ingelheim Investigational Site
city: São Paulo
country: Brazil
facility: 1160.71.0643 Boehringer Ingelheim Investigational Site
city: Pleven
country: Bulgaria
facility: 1160.71.0620 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 1160.71.0611 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 1160.71.0612 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 1160.71.0615 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 1160.71.0617 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 1160.71.0618 Boehringer Ingelheim Investigational Site
city: Sofia
country: Bulgaria
facility: 1160.71.0625 Boehringer Ingelheim Investigational Site
city: Calgary
country: Canada
facility: 1160.71.0694 Boehringer Ingelheim Investigational Site
state: Alberta
city: Calgary
country: Canada
facility: 1160.71.0696 Boehringer Ingelheim Investigational Site
state: Alberta
city: Coquitlam
country: Canada
facility: 1160.71.0680 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Coquitlam
country: Canada
facility: 1160.71.0712 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Kelowna
country: Canada
facility: 1160.71.0706 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Nanaimo
country: Canada
facility: 1160.71.0725 Boehringer Ingelheim Investigational Site
state: British Columbia
city: New Westminster
country: Canada
facility: 1160.71.0691 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Victoria
country: Canada
facility: 1160.71.0714 Boehringer Ingelheim Investigational Site
state: British Columbia
city: Portage la Prairie
country: Canada
facility: 1160.71.0701 Boehringer Ingelheim Investigational Site
state: Manitoba
city: Halifax
country: Canada
facility: 1160.71.0703 Boehringer Ingelheim Investigational Site
state: Nova Scotia
city: Burlington
country: Canada
facility: 1160.71.0674 Boehringer Ingelheim Investigational Site
state: Ontario
city: Cambridge
country: Canada
facility: 1160.71.0702 Boehringer Ingelheim Investigational Site
state: Ontario
city: Cambridge
country: Canada
facility: 1160.71.0720 Boehringer Ingelheim Investigational Site
state: Ontario
city: Grimsby
country: Canada
facility: 1160.71.0692 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 1160.71.0697 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 1160.71.0710 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 1160.71.0719 Boehringer Ingelheim Investigational Site
state: Ontario
city: Hamilton
country: Canada
facility: 1160.71.0721 Boehringer Ingelheim Investigational Site
state: Ontario
city: Mississauga
country: Canada
facility: 1160.71.0708 Boehringer Ingelheim Investigational Site
state: Ontario
city: Newmarket
country: Canada
facility: 1160.71.0688 Boehringer Ingelheim Investigational Site
state: Ontario
city: Oshawa
country: Canada
facility: 1160.71.0672 Boehringer Ingelheim Investigational Site
state: Ontario
city: Ottawa
country: Canada
facility: 1160.71.0687 Boehringer Ingelheim Investigational Site
state: Ontario
city: Scarborough
country: Canada
facility: 1160.71.0679 Boehringer Ingelheim Investigational Site
state: Ontario
city: Scarborough
country: Canada
facility: 1160.71.0723 Boehringer Ingelheim Investigational Site
state: Ontario
city: Sudbury
country: Canada
facility: 1160.71.0715 Boehringer Ingelheim Investigational Site
state: Ontario
city: Thunder Bay
country: Canada
facility: 1160.71.0690 Boehringer Ingelheim Investigational Site
state: Ontario
city: Toronto
country: Canada
facility: 1160.71.0684 Boehringer Ingelheim Investigational Site
state: Ontario
city: Toronto
country: Canada
facility: 1160.71.0718 Boehringer Ingelheim Investigational Site
state: Ontario
city: Windsor
country: Canada
facility: 1160.71.0686 Boehringer Ingelheim Investigational Site
state: Ontario
city: Montreal
country: Canada
facility: 1160.71.0683 Boehringer Ingelheim Investigational Site
state: Quebec
city: Montreal
country: Canada
facility: 1160.71.0705 Boehringer Ingelheim Investigational Site
state: Quebec
city: Montreal
country: Canada
facility: 1160.71.0709 Boehringer Ingelheim Investigational Site
state: Quebec
city: Montreal
country: Canada
facility: 1160.71.0716 Boehringer Ingelheim Investigational Site
state: Quebec
city: Quebec City
country: Canada
facility: 1160.71.0717 Boehringer Ingelheim Investigational Site
state: Quebec
city: St. Charles-Borromee
country: Canada
facility: 1160.71.0699 Boehringer Ingelheim Investigational Site
state: Quebec
city: St. George-de-Beauce
country: Canada
facility: 1160.71.0713 Boehringer Ingelheim Investigational Site
state: Quebec
city: St. Hyacinthe
country: Canada
facility: 1160.71.0675 Boehringer Ingelheim Investigational Site
state: Quebec
city: Saskatoon
country: Canada
facility: 1160.71.0673 Boehringer Ingelheim Investigational Site
state: Saskatchewan
city: Saskatoon
country: Canada
facility: 1160.71.0678 Boehringer Ingelheim Investigational Site
state: Saskatchewan
city: Quebec
country: Canada
facility: 1160.71.0700 Boehringer Ingelheim Investigational Site
city: Beijing
country: China
facility: 1160.71.0771 Boehringer Ingelheim Investigational Site
city: Beijing
country: China
facility: 1160.71.0772 Boehringer Ingelheim Investigational Site
city: Beijing
country: China
facility: 1160.71.0773 Boehringer Ingelheim Investigational Site
city: Beijing
country: China
facility: 1160.71.0774 Boehringer Ingelheim Investigational Site
city: Haerbin
country: China
facility: 1160.71.0776 Boehringer Ingelheim Investigational Site
city: Hangzhou
country: China
facility: 1160.71.0784 Boehringer Ingelheim Investigational Site
city: QingDao
country: China
facility: 1160.71.0778 Boehringer Ingelheim Investigational Site
city: Shanghai
country: China
facility: 1160.71.0781 Boehringer Ingelheim Investigational Site
city: Shanghai
country: China
facility: 1160.71.0782 Boehringer Ingelheim Investigational Site
city: Shenyang
country: China
facility: 1160.71.0777 Boehringer Ingelheim Investigational Site
city: Shijiazhuang
country: China
facility: 1160.71.0780 Boehringer Ingelheim Investigational Site
city: Modrice
country: Czech Republic
facility: 1160.71.0816 Boehringer Ingelheim Investigational Site
city: Ostrava 1
country: Czech Republic
facility: 1160.71.0820 Boehringer Ingelheim Investigational Site
city: Pardubice
country: Czech Republic
facility: 1160.71.0818 Boehringer Ingelheim Investigational Site
city: Plzen-Bory
country: Czech Republic
facility: 1160.71.0814 Boehringer Ingelheim Investigational Site
city: Praha 5
country: Czech Republic
facility: 1160.71.0811 Boehringer Ingelheim Investigational Site
city: Praha 6
country: Czech Republic
facility: 1160.71.0812 Boehringer Ingelheim Investigational Site
city: Praha 9
country: Czech Republic
facility: 1160.71.0813 Boehringer Ingelheim Investigational Site
city: Pribram
country: Czech Republic
facility: 1160.71.0817 Boehringer Ingelheim Investigational Site
city: Usti nad Orlici
country: Czech Republic
facility: 1160.71.0819 Boehringer Ingelheim Investigational Site
city: Aalborg
country: Denmark
facility: 1160.71.0837 Boehringer Ingelheim Investigational Site
city: Aarhus C
country: Denmark
facility: 1160.71.0835 Boehringer Ingelheim Investigational Site
city: Frederikssund
country: Denmark
facility: 1160.71.0838 Boehringer Ingelheim Investigational Site
city: Helsingør
country: Denmark
facility: 1160.71.0833 Boehringer Ingelheim Investigational Site
city: Herlev
country: Denmark
facility: 1160.71.0834 Boehringer Ingelheim Investigational Site
city: Horsens
country: Denmark
facility: 1160.71.0841 Boehringer Ingelheim Investigational Site
city: Hvidovre
country: Denmark
facility: 1160.71.0832 Boehringer Ingelheim Investigational Site
city: Køge
country: Denmark
facility: 1160.71.0840 Boehringer Ingelheim Investigational Site
city: Odense
country: Denmark
facility: 1160.71.0831 Boehringer Ingelheim Investigational Site
city: Roskilde
country: Denmark
facility: 1160.71.0839 Boehringer Ingelheim Investigational Site
city: Svendborg
country: Denmark
facility: 1160.71.0836 Boehringer Ingelheim Investigational Site
city: Helsinki
country: Finland
facility: 1160.71.0851 Boehringer Ingelheim Investigational Site
city: Jyväskylä
country: Finland
facility: 1160.71.0859 Boehringer Ingelheim Investigational Site
city: Oulu
country: Finland
facility: 1160.71.0854 Boehringer Ingelheim Investigational Site
city: Pori
country: Finland
facility: 1160.71.0858 Boehringer Ingelheim Investigational Site
city: Tampere
country: Finland
facility: 1160.71.0852 Boehringer Ingelheim Investigational Site
city: Turku
country: Finland
facility: 1160.71.0853 Boehringer Ingelheim Investigational Site
city: ABBEVILLE cedex
country: France
facility: 1160.71.875A Boehringer Ingelheim Investigational Site
city: Angers
country: France
facility: 1160.71.882D Boehringer Ingelheim Investigational Site
city: Angers
country: France
facility: 1160.71.882G Boehringer Ingelheim Investigational Site
city: Besle Sur Vilaine
country: France
facility: 1160.71.879F Boehringer Ingelheim Investigational Site
city: Cholet
country: France
facility: 1160.71.887A Boehringer Ingelheim Investigational Site
city: Château Gontier
country: France
facility: 1160.71.882K Boehringer Ingelheim Investigational Site
city: Derval
country: France
facility: 1160.71.879C Boehringer Ingelheim Investigational Site
city: Feneu
country: France
facility: 1160.71.882H Boehringer Ingelheim Investigational Site
city: GRENOBLE Cédex 9
country: France
facility: 1160.71.888A Boehringer Ingelheim Investigational Site
city: La Chapelle sur Erdre
country: France
facility: 1160.71.879B Boehringer Ingelheim Investigational Site
city: Langres
country: France
facility: 1160.71.874A Boehringer Ingelheim Investigational Site
city: Laval
country: France
facility: 1160.71.884A Boehringer Ingelheim Investigational Site
city: Le Mesnil en Valée
country: France
facility: 1160.71.880B Boehringer Ingelheim Investigational Site
city: Murs Erigne
country: France
facility: 1160.71.880A Boehringer Ingelheim Investigational Site
city: Nantes
country: France
facility: 1160.71.879A Boehringer Ingelheim Investigational Site
city: Nantes
country: France
facility: 1160.71.879H Boehringer Ingelheim Investigational Site
city: Nantes
country: France
facility: 1160.71.879S Boehringer Ingelheim Investigational Site
city: Parcay les Pins
country: France
facility: 1160.71.880J Boehringer Ingelheim Investigational Site
city: Paris
country: France
facility: 1160.71.871A Boehringer Ingelheim Investigational Site
city: Saint Aubin Des Chateaux
country: France
facility: 1160.71.879E Boehringer Ingelheim Investigational Site
city: Segre
country: France
facility: 1160.71.880D Boehringer Ingelheim Investigational Site
city: Tierce
country: France
facility: 1160.71.882A Boehringer Ingelheim Investigational Site
city: Tierce
country: France
facility: 1160.71.882B Boehringer Ingelheim Investigational Site
city: Tierce
country: France
facility: 1160.71.882C Boehringer Ingelheim Investigational Site
city: Vieillevigne
country: France
facility: 1160.71.879G Boehringer Ingelheim Investigational Site
city: Vihiers
country: France
facility: 1160.71.880E Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1160.71.0932 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1160.71.0948 Boehringer Ingelheim Investigational Site
city: Berlin
country: Germany
facility: 1160.71.0962 Boehringer Ingelheim Investigational Site
city: Bochum
country: Germany
facility: 1160.71.0940 Boehringer Ingelheim Investigational Site
city: Dortmund
country: Germany
facility: 1160.71.0972 Boehringer Ingelheim Investigational Site
city: Essen
country: Germany
facility: 1160.71.0934 Boehringer Ingelheim Investigational Site
city: Frankfurt am Main
country: Germany
facility: 1160.71.0931 Boehringer Ingelheim Investigational Site
city: Heidelberg
country: Germany
facility: 1160.71.0943 Boehringer Ingelheim Investigational Site
city: Köln
country: Germany
facility: 1160.71.0963 Boehringer Ingelheim Investigational Site
city: Lahr
country: Germany
facility: 1160.71.0946 Boehringer Ingelheim Investigational Site
city: Limburg
country: Germany
facility: 1160.71.0944 Boehringer Ingelheim Investigational Site
city: Mainz
country: Germany
facility: 1160.71.0951 Boehringer Ingelheim Investigational Site
city: Mannheim
country: Germany
facility: 1160.71.0933 Boehringer Ingelheim Investigational Site
city: Mannheim
country: Germany
facility: 1160.71.0945 Boehringer Ingelheim Investigational Site
city: Mannheim
country: Germany
facility: 1160.71.0970 Boehringer Ingelheim Investigational Site
city: Witten
country: Germany
facility: 1160.71.0937 Boehringer Ingelheim Investigational Site
city: Wuppertal
country: Germany
facility: 1160.71.0966 Boehringer Ingelheim Investigational Site
city: Athens
country: Greece
facility: 1160.71.0901 Boehringer Ingelheim Investigational Site
city: Kalamaria-Thessaloniki
country: Greece
facility: 1160.71.0914 Boehringer Ingelheim Investigational Site
city: Larissa
country: Greece
facility: 1160.71.0904 Boehringer Ingelheim Investigational Site
city: Thiva
country: Greece
facility: 1160.71.0910 Boehringer Ingelheim Investigational Site
city: Trikala
country: Greece
facility: 1160.71.0903 Boehringer Ingelheim Investigational Site
city: Voula - Athens
country: Greece
facility: 1160.71.0905 Boehringer Ingelheim Investigational Site
city: Kowloon
country: Hong Kong
facility: 1160.71.1003 Boehringer Ingelheim Investigational Site
city: Kowloon
country: Hong Kong
facility: 1160.71.1004 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 1160.71.1011 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 1160.71.1012 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 1160.71.1013 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 1160.71.1014 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 1160.71.1015 Boehringer Ingelheim Investigational Site
city: Budapest
country: Hungary
facility: 1160.71.1016 Boehringer Ingelheim Investigational Site
city: Gyongyos
country: Hungary
facility: 1160.71.1020 Boehringer Ingelheim Investigational Site
city: Komarom
country: Hungary
facility: 1160.71.1017 Boehringer Ingelheim Investigational Site
city: Pecs
country: Hungary
facility: 1160.71.1018 Boehringer Ingelheim Investigational Site
city: Ahmedabad-52
country: India
facility: 1160.71.1056 Boehringer Ingelheim Investigational Site
city: Ahmedabad
country: India
facility: 1160.71.1057 Boehringer Ingelheim Investigational Site
city: Bangalore
country: India
facility: 1160.71.1065 Boehringer Ingelheim Investigational Site
city: Hyderabad
country: India
facility: 1160.71.1062 Boehringer Ingelheim Investigational Site
city: Jaipur, Rajasthan
country: India
facility: 1160.71.1073 Boehringer Ingelheim Investigational Site
city: Kerala
country: India
facility: 1160.71.1067 Boehringer Ingelheim Investigational Site
city: Kottayam
country: India
facility: 1160.71.1068 Boehringer Ingelheim Investigational Site
city: Lucknow, Uttar Pradesh
country: India
facility: 1160.71.1055 Boehringer Ingelheim Investigational Site
city: Ludhiana
country: India
facility: 1160.71.1051 Boehringer Ingelheim Investigational Site
city: Mysore
country: India
facility: 1160.71.1072 Boehringer Ingelheim Investigational Site
city: Nagpur-12
country: India
facility: 1160.71.1059 Boehringer Ingelheim Investigational Site
city: New Delhi
country: India
facility: 1160.71.1052 Boehringer Ingelheim Investigational Site
city: Pune, Maharashtra
country: India
facility: 1160.71.1070 Boehringer Ingelheim Investigational Site
city: Afula
country: Israel
facility: 1160.71.1110 Boehringer Ingelheim Investigational Site
city: Afula
country: Israel
facility: 1160.71.1121 Boehringer Ingelheim Investigational Site
city: Ashkelon
country: Israel
facility: 1160.71.1111 Boehringer Ingelheim Investigational Site
city: Givatayim
country: Israel
facility: 1160.71.1117 Boehringer Ingelheim Investigational Site
city: Hadera
country: Israel
facility: 1160.71.1112 Boehringer Ingelheim Investigational Site
city: Haifa
country: Israel
facility: 1160.71.1091 Boehringer Ingelheim Investigational Site
city: Haifa
country: Israel
facility: 1160.71.1113 Boehringer Ingelheim Investigational Site
city: Haifa
country: Israel
facility: 1160.71.1114 Boehringer Ingelheim Investigational Site
city: Haifa
country: Israel
facility: 1160.71.1116 Boehringer Ingelheim Investigational Site
city: Haifa
country: Israel
facility: 1160.71.1118 Boehringer Ingelheim Investigational Site
city: Holon
country: Israel
facility: 1160.71.1105 Boehringer Ingelheim Investigational Site
city: Jerusalem
country: Israel
facility: 1160.71.1101 Boehringer Ingelheim Investigational Site
city: Jerusalem
country: Israel
facility: 1160.71.1104 Boehringer Ingelheim Investigational Site
city: Jerusalem
country: Israel
facility: 1160.71.1106 Boehringer Ingelheim Investigational Site
city: Kfar Saba
country: Israel
facility: 1160.71.1119 Boehringer Ingelheim Investigational Site
city: Petah Tikva
country: Israel
facility: 1160.71.1096 Boehringer Ingelheim Investigational Site
city: Ramat Gan
country: Israel
facility: 1160.71.1093 Boehringer Ingelheim Investigational Site
city: Ramat Gan
country: Israel
facility: 1160.71.1094 Boehringer Ingelheim Investigational Site
city: Ramat Gan
country: Israel
facility: 1160.71.1095 Boehringer Ingelheim Investigational Site
city: Rehovot
country: Israel
facility: 1160.71.1100 Boehringer Ingelheim Investigational Site
city: Safed
country: Israel
facility: 1160.71.1103 Boehringer Ingelheim Investigational Site
city: Tel Aviv
country: Israel
facility: 1160.71.1120 Boehringer Ingelheim Investigational Site
city: Tel Aviv
country: Israel
facility: 1160.71.1122 Boehringer Ingelheim Investigational Site
city: Tel-Aviv
country: Israel
facility: 1160.71.1107 Boehringer Ingelheim Investigational Site
city: Tel-Aviv
country: Israel
facility: 1160.71.1108 Boehringer Ingelheim Investigational Site
city: Tel-Aviv
country: Israel
facility: 1160.71.1109 Boehringer Ingelheim Investigational Site
city: Arezzo
country: Italy
facility: 1160.71.1169 Boehringer Ingelheim Investigational Site
city: Ascoli Piceno
country: Italy
facility: 1160.71.1172 Boehringer Ingelheim Investigational Site
city: Sassari
country: Italy
facility: 1160.71.1170 Boehringer Ingelheim Investigational Site
city: Busan
country: Korea, Republic of
facility: 1160.71.1585 Boehringer Ingelheim Investigational Site
city: Cheonan-si
country: Korea, Republic of
facility: 1160.71.1586 Boehringer Ingelheim Investigational Site
city: Daegu
country: Korea, Republic of
facility: 1160.71.1584 Boehringer Ingelheim Investigational Site
city: Daegu
country: Korea, Republic of
facility: 1160.71.1591 Boehringer Ingelheim Investigational Site
city: Gwangju
country: Korea, Republic of
facility: 1160.71.1590 Boehringer Ingelheim Investigational Site
city: Incheon
country: Korea, Republic of
facility: 1160.71.1581 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1160.71.1582 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1160.71.1583 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1160.71.1589 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1160.71.1592 Boehringer Ingelheim Investigational Site
city: Seoul
country: Korea, Republic of
facility: 1160.71.1593 Boehringer Ingelheim Investigational Site
city: Kuala Lumpur
country: Malaysia
facility: 1160.71.1291 Boehringer Ingelheim Investigational Site
city: Kuala Lumpur
country: Malaysia
facility: 1160.71.1292 Boehringer Ingelheim Investigational Site
city: 's Hertogenbosch
country: Netherlands
facility: 1160.71.1337 Boehringer Ingelheim Investigational Site
city: Almelo
country: Netherlands
facility: 1160.71.1344 Boehringer Ingelheim Investigational Site
city: Amsterdam
country: Netherlands
facility: 1160.71.1331 Boehringer Ingelheim Investigational Site
city: Apeldoorn
country: Netherlands
facility: 1160.71.1336 Boehringer Ingelheim Investigational Site
city: Breda
country: Netherlands
facility: 1160.71.1332 Boehringer Ingelheim Investigational Site
city: Den Helder
country: Netherlands
facility: 1160.71.1349 Boehringer Ingelheim Investigational Site
city: Deventer
country: Netherlands
facility: 1160.71.1345 Boehringer Ingelheim Investigational Site
city: Dirksland
country: Netherlands
facility: 1160.71.1360 Boehringer Ingelheim Investigational Site
city: Ede
country: Netherlands
facility: 1160.71.1340 Boehringer Ingelheim Investigational Site
city: Eindhoven
country: Netherlands
facility: 1160.71.1358 Boehringer Ingelheim Investigational Site
city: Enschede
country: Netherlands
facility: 1160.71.1338 Boehringer Ingelheim Investigational Site
city: Goes
country: Netherlands
facility: 1160.71.1343 Boehringer Ingelheim Investigational Site
city: Gorinchem
country: Netherlands
facility: 1160.71.1347 Boehringer Ingelheim Investigational Site
city: Groningen
country: Netherlands
facility: 1160.71.1333 Boehringer Ingelheim Investigational Site
city: Heerlen
country: Netherlands
facility: 1160.71.1361 Boehringer Ingelheim Investigational Site
city: Hengelo
country: Netherlands
facility: 1160.71.1339 Boehringer Ingelheim Investigational Site
city: Hilversum
country: Netherlands
facility: 1160.71.1346 Boehringer Ingelheim Investigational Site
city: Hoorn
country: Netherlands
facility: 1160.71.1356 Boehringer Ingelheim Investigational Site
city: Maastricht
country: Netherlands
facility: 1160.71.1359 Boehringer Ingelheim Investigational Site
city: Meppel
country: Netherlands
facility: 1160.71.1341 Boehringer Ingelheim Investigational Site
city: Rotterdam
country: Netherlands
facility: 1160.71.1354 Boehringer Ingelheim Investigational Site
city: Sneek
country: Netherlands
facility: 1160.71.1351 Boehringer Ingelheim Investigational Site
city: Tiel
country: Netherlands
facility: 1160.71.1353 Boehringer Ingelheim Investigational Site
city: Tilburg
country: Netherlands
facility: 1160.71.1352 Boehringer Ingelheim Investigational Site
city: Veldhoven
country: Netherlands
facility: 1160.71.1350 Boehringer Ingelheim Investigational Site
city: Velp
country: Netherlands
facility: 1160.71.1342 Boehringer Ingelheim Investigational Site
city: Zwijndrecht
country: Netherlands
facility: 1160.71.1348 Boehringer Ingelheim Investigational Site
city: Gjøvik
country: Norway
facility: 1160.71.1396 Boehringer Ingelheim Investigational Site
city: Moss
country: Norway
facility: 1160.71.1393 Boehringer Ingelheim Investigational Site
city: Nordbyhagen
country: Norway
facility: 1160.71.1395 Boehringer Ingelheim Investigational Site
city: Oslo
country: Norway
facility: 1160.71.1391 Boehringer Ingelheim Investigational Site
city: Oslo
country: Norway
facility: 1160.71.1397 Boehringer Ingelheim Investigational Site
city: RUD
country: Norway
facility: 1160.71.1394 Boehringer Ingelheim Investigational Site
city: Ermita Manila
country: Philippines
facility: 1160.71.1422 Boehringer Ingelheim Investigational Site
city: Manila
country: Philippines
facility: 1160.71.1421 Boehringer Ingelheim Investigational Site
city: Pasig City
country: Philippines
facility: 1160.71.1424 Boehringer Ingelheim Investigational Site
city: Quezon City
country: Philippines
facility: 1160.71.1423 Boehringer Ingelheim Investigational Site
city: Quezon City
country: Philippines
facility: 1160.71.1425 Boehringer Ingelheim Investigational Site
city: Gdynia
country: Poland
facility: 1160.71.1436 Boehringer Ingelheim Investigational Site
city: Gdynia
country: Poland
facility: 1160.71.1437 Boehringer Ingelheim Investigational Site
city: Gdynia
country: Poland
facility: 1160.71.1438 Boehringer Ingelheim Investigational Site
city: Pulawy
country: Poland
facility: 1160.71.1433 Boehringer Ingelheim Investigational Site
city: Warsaw
country: Poland
facility: 1160.71.1431 Boehringer Ingelheim Investigational Site
city: Warsaw
country: Poland
facility: 1160.71.1432 Boehringer Ingelheim Investigational Site
city: Zabrze
country: Poland
facility: 1160.71.1434 Boehringer Ingelheim Investigational Site
city: Amadora
country: Portugal
facility: 1160.71.1456 Boehringer Ingelheim Investigational Site
city: Carnaxide
country: Portugal
facility: 1160.71.1451 Boehringer Ingelheim Investigational Site
city: Coimbra
country: Portugal
facility: 1160.71.1454 Boehringer Ingelheim Investigational Site
city: Coimbra
country: Portugal
facility: 1160.71.1459 Boehringer Ingelheim Investigational Site
city: Covilhã
country: Portugal
facility: 1160.71.1457 Boehringer Ingelheim Investigational Site
city: Porto
country: Portugal
facility: 1160.71.1455 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 1160.71.1471 Boehringer Ingelheim Investigational Site
city: Bucharest
country: Romania
facility: 1160.71.1472 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1160.71.1501 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1160.71.1503 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1160.71.1504 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1160.71.1505 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1160.71.1507 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1160.71.1508 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1160.71.1509 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1160.71.1510 Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: 1160.71.1511 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1160.71.1512 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1160.71.1513 Boehringer Ingelheim Investigational Site
city: St. Petersburg
country: Russian Federation
facility: 1160.71.1514 Boehringer Ingelheim Investigational Site
city: Singapore
country: Singapore
facility: 1160.71.1531 Boehringer Ingelheim Investigational Site
city: Banska Bystrica
country: Slovakia
facility: 1160.71.1548 Boehringer Ingelheim Investigational Site
city: Bratislava
country: Slovakia
facility: 1160.71.1541 Boehringer Ingelheim Investigational Site
city: Bratislava
country: Slovakia
facility: 1160.71.1542 Boehringer Ingelheim Investigational Site
city: Bratislava
country: Slovakia
facility: 1160.71.1543 Boehringer Ingelheim Investigational Site
city: Kosice
country: Slovakia
facility: 1160.71.1550 Boehringer Ingelheim Investigational Site
city: Zilina
country: Slovakia
facility: 1160.71.1547 Boehringer Ingelheim Investigational Site
city: Göteborg
country: Sweden
facility: 1160.71.1633 Boehringer Ingelheim Investigational Site
city: Malmö
country: Sweden
facility: 1160.71.1627 Boehringer Ingelheim Investigational Site
city: Norrköping
country: Sweden
facility: 1160.71.1625 Boehringer Ingelheim Investigational Site
city: Nässjö
country: Sweden
facility: 1160.71.1628 Boehringer Ingelheim Investigational Site
city: Stockholm
country: Sweden
facility: 1160.71.1626 Boehringer Ingelheim Investigational Site
city: Stockholm
country: Sweden
facility: 1160.71.1634 Boehringer Ingelheim Investigational Site
city: Umeå
country: Sweden
facility: 1160.71.1624 Boehringer Ingelheim Investigational Site
city: Uppsala
country: Sweden
facility: 1160.71.1621 Boehringer Ingelheim Investigational Site
city: Uppsala
country: Sweden
facility: 1160.71.1635 Boehringer Ingelheim Investigational Site
city: Västerås
country: Sweden
facility: 1160.71.1622 Boehringer Ingelheim Investigational Site
city: Örebro
country: Sweden
facility: 1160.71.1623 Boehringer Ingelheim Investigational Site
city: Basel
country: Switzerland
facility: 1160.71.1652 Boehringer Ingelheim Investigational Site
city: Bellinzona
country: Switzerland
facility: 1160.71.1655 Boehringer Ingelheim Investigational Site
city: Bern
country: Switzerland
facility: 1160.71.1651 Boehringer Ingelheim Investigational Site
city: Lugano
country: Switzerland
facility: 1160.71.1654 Boehringer Ingelheim Investigational Site
city: Changhua
country: Taiwan
facility: 1160.71.1680 Boehringer Ingelheim Investigational Site
city: Hualien
country: Taiwan
facility: 1160.71.1683 Boehringer Ingelheim Investigational Site
city: Kaohsiung
country: Taiwan
facility: 1160.71.1682 Boehringer Ingelheim Investigational Site
city: Taichung
country: Taiwan
facility: 1160.71.1679 Boehringer Ingelheim Investigational Site
city: Tainan
country: Taiwan
facility: 1160.71.1681 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1160.71.1671 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1160.71.1672 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1160.71.1673 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1160.71.1674 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1160.71.1675 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1160.71.1676 Boehringer Ingelheim Investigational Site
city: Taipei
country: Taiwan
facility: 1160.71.1677 Boehringer Ingelheim Investigational Site
city: Taoyuan
country: Taiwan
facility: 1160.71.1678 Boehringer Ingelheim Investigational Site
city: Bangkok
country: Thailand
facility: 1160.71.1701 Boehringer Ingelheim Investigational Site
city: Chiang Mai
country: Thailand
facility: 1160.71.1703 Boehringer Ingelheim Investigational Site
city: Khon Kaen
country: Thailand
facility: 1160.71.1704 Boehringer Ingelheim Investigational Site
city: Birmingham
country: United Kingdom
facility: 1160.71.1744 Boehringer Ingelheim Investigational Site
city: Chertsey
country: United Kingdom
facility: 1160.71.1746 Boehringer Ingelheim Investigational Site
city: County Armagh
country: United Kingdom
facility: 1160.71.1745 Boehringer Ingelheim Investigational Site
city: Kirkcaldy, Fife
country: United Kingdom
facility: 1160.71.1755 Boehringer Ingelheim Investigational Site
city: London
country: United Kingdom
facility: 1160.71.1741 Boehringer Ingelheim Investigational Site
city: Newcastle upon Tyne
country: United Kingdom
facility: 1160.71.1742 Boehringer Ingelheim Investigational Site
city: Newport
country: United Kingdom
facility: 1160.71.1751 Boehringer Ingelheim Investigational Site
city: Northampton
country: United Kingdom
facility: 1160.71.1752 Boehringer Ingelheim Investigational Site
city: Romford, Essex
country: United Kingdom
facility: 1160.71.1743 Boehringer Ingelheim Investigational Site
city: York
country: United Kingdom
facility: 1160.71.1748 Boehringer Ingelheim Investigational Site
Study officials:
affiliation: Boehringer Ingelheim
name: Boehringer Ingelheim
role: STUDY_CHAIR
References:
citation: Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation. 2013 Jul 16;128(3):237-43. doi: 10.1161/CIRCULATIONAHA.112.001139. Epub 2013 Jun 14.